G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro

This publication has 23 references indexed in Scilit:

• Expression of thebcl-2Gene from a Defective HSV-1 Amplicon Vector Protects Pancreaticβ-Cells from Apoptosis
  Human Gene Therapy, 1996
• Gene Therapy of Metastatic Pancreas Cancer with Intraperitoneal Injections of Concentrated Retroviral Herpes Simplex Thymidine Kinase Vector Supernatant and Ganciclovir
  Annals of Surgery, 1996
• The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth.
  Molecular and Cellular Biology, 1994
• An experimental model of retrovirus gene therapy for malignant brain tumors
  Journal of Neurosurgery, 1993
• Genotoxic‐Stress‐Response Genes and Growth‐Arrest Genes
  Annals of the New York Academy of Sciences, 1992
• In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
  Science, 1992
• Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65
  Journal of General Virology, 1992
• Mapping of Herpes Simplex Virus-1 Neurovirulence to γ ₁ 34.5, a Gene Nonessential for Growth in Culture
  Science, 1990
• Characterization of a New Primary Human Pancreatic Tumor Line
  Cancer Investigation, 1986
• Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase
  International Journal of Cancer, 1977